Serum biomarkers in systemic sclerosis-associated pulmonary fibrosis: KL-6 correlates with disease severity

被引：0
|
作者：
Hoyles, R. K. [1 ]
Sato, H. [1 ]
Desai, S. R. [2 ]
Goh, N. S. L. [1 ]
Woodhead, F. A. [1 ]
Black, C. M. [3 ]
Du Bois, R. M. [1 ]
Denton, C. P. [3 ]
Wells, A. U. [1 ]
机构：
[1] Royal Brompton Hosp, Interstitial Lung Dis Unit, London SW3 6LY, England
[2] Kings Coll Hosp London, Dept Radiol, London, England
[3] Univ London Royal Free Hosp, Coll Med, Ctr Rheumatol, London, England
来源：
THORAX | 2007年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A24 / A25
页数：2
相关论文
共 50 条
  • [1] SEASONAL VARIATION OF SERUM KL-6 LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Hirose, H.
    Higuchi, T.
    Takagi, K.
    Tochimoto, A.
    Kawaguchi, Y.
    Harigai, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1646 - 1647
  • [2] Effect of Nintedanib on KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Assassi, Shervin
    Denton, Christopher
    Cutolo, Maurizio
    Luckhardt, Tracy
    Diefenbach, Claudia
    Ittrich, Carina
    Alves, Margarida
    Kuwana, Masataka
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 828 - 829
  • [3] Elevated sevum KL-6 levels in patients with systemic sclerosis: Association with the severity of pulmonary fibrosis
    Sato, S
    Nagaoka, T
    Hasegawa, M
    Nishijima, C
    Takehara, K
    DERMATOLOGY, 2000, 200 (03) : 196 - 201
  • [4] Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis
    Yamane, K
    Ihn, H
    Kubo, M
    Yazawa, N
    Kikuchi, K
    Soma, Y
    Tamaki, K
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (04) : 930 - 934
  • [5] Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease
    Watanabe, Satoshi
    Kase, Kazumasa
    Saeki, Keigo
    Ohkura, Noriyuki
    Murata, Akari
    Waseda, Yuko
    Takato, Hazuki
    Ichikawa, Yukari
    Yasui, Masahide
    Kasahara, Kazuo
    RESPIRATORY MEDICINE, 2022, 191
  • [6] Disease progression and changes in KL-6 in patients with limited cutaneous systemic sclerosis-associated interstitial lung disease
    Takei, Reoto
    Yamano, Yasuhiko
    Kataoka, Kensuke
    Fukihara, Jun
    Sasano, Hajime
    Yokoyama, Toshiki
    Matsuda, Toshiaki
    Kimura, Tomoki
    Kondoh, Yasuhiro
    RESPIRATORY INVESTIGATION, 2024, 62 (01) : 44 - 48
  • [7] Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis
    Yanaba, K
    Hasegawa, M
    Hamaguchi, Y
    Fujimoto, M
    Takehara, K
    Sato, S
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (04) : 429 - 436
  • [8] Progress in progressive pulmonary fibrosis: biomarkers of systemic sclerosis-associated interstitial lung disease
    Takada, Toshinori
    RHEUMATOLOGY, 2024, 63 (11) : 2907 - 2908
  • [9] Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis
    Sanges, Sebastien
    Rice, Lisa
    Tu, Ly
    Valenzi, Eleanor
    Cracowski, Jean-Luc
    Montani, David
    Mantero, Julio C.
    Ternynck, Camille
    Marot, Guillemette
    Bujor, Andreea M.
    Hachulla, Eric
    Launay, David
    Humbert, Marc
    Guignabert, Christophe
    Lafyatis, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03) : 365 - 373
  • [10] Association of serum KL-6 with systemic sclerosis associated interstitial lung disease: a meta-analysis
    Yang, G.
    Chen, S.
    Shi, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 879 - 879
12345